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Abstract
Opium addiction and cutaneous leishmaniasis (CL) are endemic in different parts of Iran, particularly in Bam, where a
massive earthquake occurred. This study was designed to compare the incidence rate and severity of CL cases among
opium addicted and non-addicted individuals in south-eastern Iran. This study was carried out as a prospective cohort by
active house-to-house visits of 1,481 habitants in Bam. CL cases were confirmed by smear and identification of Leishmania
species was performed using nested-PCR. The data was analyzed by x2 and t-tests, using SPSS software and also Kaplan-
Meier survival curve and long-rank test in Stata 11.2 and P,0.05 was considered as significant. A total of 904 individuals
consisting of 226 opium addicted and 678 non-addicted individuals were followed-up for a period of seven years. The two
cohorts were similar in terms of age, sex and place of residency. A similar pattern of incidence was observed among the two
cohort groups. In contrast, the severity of CL in terms of the number, duration and the size of the lesions in opium addicted
individuals was significantly (P,0.001) higher than non-opium addicted individuals. In conclusion, the present findings
indicate that there is no relationship between the incidence of CL and opium addiction.
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Introduction
Opium abuse is a serious public health threat in Iran and in
neighbouring countries. Opiates are the most commonly used
drugs, notably in Asia and Europe, while heroin is the most widely
consumed opiate, worldwide [1]. Two thirds of opium which is not
converted into heroin is consumed in just five countries [2]: Iran
(42%), Afghanistan (7%), Pakistan (7%), India (6%) and the
Russian Federation (5%). According to the United Nation World
Drug Report (UNWDR), the highest proportion of opium
addiction in the world is reported from Iran; it is estimated that
2.8% of the population over age 15 years old are addicted, while
the world consumption rate is about 0.5% [3]. As a pain killer
opiates have been used in Iran for centuries, although use and
trade are officially illegal with harsh penalties, opiate trafficking
and consumption are major health problems in the country [4].
The current situation forced the government to implement a
number of actions including support and treatment for addicts and
rehabilitation centers to initiate prophylactic measures [5].
Leishmaniasis is reported in 98 countries and territories, with
prevalence of 12 million people and annual incidence of about 2
million [6]. Cutaneous leishmaniasis (CL) makes up 75% of the
total cases in which 90% of the patients are from Afghanistan,
Algeria, Iran, Iraq, Saudi Arabia, Syria, Brazil and Peru [7].
Leishmaniasis is among the emerging diseases which has recently
had an enormous impact on public health aspects and well-being
[6,8]. CL exists in two epidemiological forms: zoonotic CL (ZCL),
due to Leishmania major which presents in rural areas where the
gerbil is the main reservoir host with Phlebotomus papatasi as a
vector. Anthroponotic CL (ACL) is caused by L. tropica in large and
medium size cities, where humans are the main reservoir host and
P. sergenti, the main vector. The city of Bam is a well-known focus
for ACL where it has been endemic since ancient times [9].
Recent surveillance shows that opium addiction and CL incidence
have significantly increased in different provinces of Iran during
the last decade [3,10]. The increase in CL incidence and
expansion of the disease to new regions are attributed to new
settlements, urbanization, agricultural development, migration,
improvement of reporting systems and ecological changes such as
earthquakes [11,12,13]. Among the opioids, opium is the major
drug of abuse (over 85%), mainly among males in Bam, and the
ratio of males to females is 13.5 to 1.
The Bam district is located in the south-eastern province of
Kerman, 1000 m above sea level and covers an area of 168,000
km2 with a population of 250,000. A major 6.6 Richter scale
earthquake struck Bam and the neighbouring areas on 26th
December, 2003. The earthquake was particularly destructive,
resulting in approximately 30,000 deaths, 60,000 homeless and
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injuring an additional 30,000 and over 90% of the medical and
health infrastructures were destroyed [14].
Psychologically, the earthquake had a profound impact on its
victims and not just in the immediate aftermath [15]. Opium is
widely used as a pain killer [16] and Bam is located on the traffic
trade route from Afghanistan and Pakistan and as such opium is
easily available.
There are studies on prevalence of opium abuse in Iran [17–
19], but to our knowledge there is no study to evaluate the effect of
opium on CL, nationally or abroad. The objective of the present
study was to assess the relationship between CL incidence and the
severity of the disease among opium addicted and non -opium
addicted individuals in the Bam district.
Population, Materials and Methods
Ethical Consideration and Recruitment
The study protocol was approved by the Ethics Committee of
Kerman University of Medical Sciences and Health Services
(protocol contract no.89/147 and ethic no.16/9/k).
The approved protocol included the screening procedures,
interview and physical exam of the volunteers were performed by
the personnel and the physicians of the research team.
Before the screening and selection of volunteers, several
meetings with the household members and community leaders
were organized and the aims, procedure of the study, potential
benefits and harms were described. Candidates who were willing
to participate and sign an informed consent were enrolled.
Participants who contracted CL during the follow-up period were
clinically examined and treated with meglumine antimoniate
(Glucantime) alone or in combination with cryotherapy free of
charge. In addition, individuals suspected of having any other
disease were referred to the district hospital for further follow-up
examinations and proper treatment.
Study Design
This study was designed as a comparative cohort of two parallel
groups of opium addicted and non-addicted resident of Bam
district.
Selection of Participants
The study design is summarized in Fig. 1. Initially, 2,448
household members were screened. A total of 480 households with
2,026 individuals, 1–78 years old were interviewed and physically
examined by a team of experienced health workers for possible
illness and history of opium consumption and active CL lesion or
scars resembling CL. Approximately 100 households with 422
individuals refused to participate in the study. Altogether, 545
individuals with a history of CL or other diseases were excluded
and 1,481 (73.1%) were eligible and included in the study and 577
(39%) were excluded due to the following reasons; age less than 20
years, age/sex matching and consent withdrawal or addiction after
the earthquake. Overall, 904 eligible participants were included in
the two arms of the study: opium addicted (n= 226) and non-
addicted (n = 678). Finally, the participants were clinically
examined and a questionnaire was completed for each individual,
including demographic and clinical information.
Definition of Opium Addicted Case
In this study, opium addiction was defined as an individual who
consumes opium by oral inhalation on a daily basis for a period of
at least 12 months. The addiction was identified by self-introduced
through house-to-house visits and was clinically confirmed by an
experienced physician based on the method proposed by Gilrame
[20].
Confirmation of CL
Slit-skin smear was taken from the edge of the clinically active
CL lesion. Two glass slides were prepared; one for direct smear
preparation, fixed with methanol and stained by Giemsa and the
other smear was used for DNA extraction and the subsequent
molecular identification of the species of the causative agent.
Follow- up Examination
A clinic was specifically assigned and used for the management
of the patients, including opium addicted and CL patients. This
clinic was used as a headquarters for team activities such as
Figure 1. Study design.
doi:10.1371/journal.pone.0089043.g001
Table 1. Baseline characteristics of study participants.
Characteristic
Population
Number (%)
Opium addiction
Number (%)
Cutaneous
leishmaniasis
Number (%)
Age (year) ,6 118(5.8) 0(0) 39(15.7)
6–20 280(13.8) 6(2.1) 75(30.1)
21–65 1379(68.1) 185(13.4) 117(47.0)
.65 249(12.3) 57(22.9) 18(7.2)
Total 2026(100.0) 248(100.0) 249(100.0)
Sex Male 1025(50.6) 231(93.1) 108(43.4)
Female 1001(49.4) 17(6.9) 141(56.6)
doi:10.1371/journal.pone.0089043.t001
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meetings, reviewing of the study activities and also for implemen-
tation of preventive measures and research purposes. Active case-
finding was done by households visit and clinical examination
every 6 months for 7 years. Participants with suspected lesions
which lasted for more than 2 weeks were referred for parasito-
logical examinations as previously mentioned. The characteristics
of the lesions such as number and size of the lesions, locations,
onset and the severity of lesions were recorded. The size of
indurations was measured using Sokal’s method [21].
Molecular Identification
DNA preparation. DNA was collected from direct smears.
Smear scrapings were transferred into micro tubes and washed
(3000 rpm at 4uC for 10 min) three times using sterile PBS
(pH=7.2). DNA was extracted by proteinase k using the High
Pure Template Purification Kit (Roche, Germany) according to
the manufacture’s manual.
– The nested-PCR was carried out as des-
cribed by Noyes et al. 1998[22] using external primers CSB1XR,
(ATTTTTCGCGATTTTCGCAGAACG(and CSB2XF (CGA-
GAACGCCCCT) for amplification of variable minicircle frag-
ments of Leishmania kDNA.
The PCR products were visualized by 1.5% agarose gel
electrophoresis (Uvitech, Cambridge UK), using a 100- bp DNA
size marker. L. tropica (MHOM/Sudan/58/OD strain), and L.
major (MHOM/IR/02/Mash2 strain) were used as positive and
double-distilled water as negative controls. L. tropica and L. major
provided fragments of 750 bp and 560 bp, respectively. Con-
firmed cases were treated free of charge, according to National
Guidelines.
Statistical Analysis
Data was entered into a computer and standard statistical tests
to determine the significance of differences between proportions
(x2) and between means (t test) were used. The rate of CL
incidence in the opium addicted and non-addicted cohorts were
calculated as relative risk (RR), where RR is the ratio of the
incidence rate in opium addicted group to that in non-addicted
group. P,0.05 was considered as significance. The Kaplan-Meier
survival curve and long-rank test, in Stata 11.2, were used to test
equality of survival distribution between opium addicted and non-
addicted groups.
Results
Overall, 2,026 participants with mean age of 37.5617.6 years,
consisting of 1,025 males (50.6%) and 1,001 females (49.4%) were
interviewed for a history of opium consumption, active lesions or
scar of CL and health conditions (Table 1). Most of the opium
addicted individuals were older than 21 years (mean age;
49.1616.3 years) and opium addiction was significantly higher
(P,0.001) in males than females and 249 participants (mean age
22.5611.7 years) showed active CL lesions or scars which was
more frequent in the age range 21–65 years than the other age
groups. The rate of CL was higher in females than males. In
addition, 9 participants showed history of acute or chronic
diseases.
A total of 904 eligible individuals (mean age 44.569.1 years),
including 226 opium addicted and 678 non–addicted volunteers
were followed–up for development of CL lesion for a period of
seven years from 2004 to 2010. Altogether, the drop-out rate
during the follow up due to death and population displacement
within the district, migration and habitual change in opium abuse
was 29%. The two cohorts were similar in respect to age, sex and
place of residency (Table 2). Most of the individuals were in the
age range of 28–40 years (35.9%) and the least number was in age
group of .52 years (29.1%) in the opium addicted and non –
Table 2. Age and sex distributions of opium addicted and
non – addicted cohorts.
Characteristic
Examined
population Addicted* Non – addicted*
Age (year ) Number (%) Number (%) Number (%)
28–40 231(35.9) 70(34.8) 161(36.4)
41–52 225(35.0) 72(35.8) 153(34.6)
.52 187(29.1) 59(29.3) 128(29.0)
Sex
Male 618(96.1) 193(96.0) 425(96.2)
Female 25(3.9) 8(4.0) 17(3.8)
*There was no significant difference among the opium addicted and non-
addicted with respect to age or gender.
doi:10.1371/journal.pone.0089043.t002
Table 3. The incidence of cutaneous leishmaniasis cases in opium addicted and non – addicted cohorts by the year of contraction.
Year
Opium addicted*
At risk population Incidence No (%)
Opium non –addicted*
At risk population Incidence No (%)
2004 201 1(0.5) 442 3(0.7)
2005 200 3(1.5) 439 7(1.6)
2006 197 11(5.6) 432 22(5.1)
2007 186 9(4.8) 410 19(4.6)
2008 177 7(3.9) 391 14(3.6)
2009 170 4(2.3) 377 12(3.2)
2010 166 3(1.8) 365 9(2.5)
Total 1297 38(2.9) 2860 86(3.0)
*There was no significant difference between the incidence rates among the two cohorts.
doi:10.1371/journal.pone.0089043.t003
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Nested PCR.
GTAGCAGAAACTCCCGTTCA) and specific internal primers
13Z (ACTGGGGGTTGGTGTAAAATAG) and LiR (TCGCA-
addicted groups. In the opium addicted group there were more
males (93.1%) than females (6.9%).
The overall mean annual incidence rate of CL was 3% which
was similarly distributed among the opium addicted and non-
addicted individuals. A similar pattern of incidence was observed
between the two cohorts (RR=18.9/19.5 = 0.97) during the seven
years follow up (Table 3). The lowest incidence rate was recorded
in 2004, however it sharply increased thereafter and reached its
highest level in 2006, which was coincident with the peak epidemic
in Bam. On the other hand, during 2007–2010, the CL rate
decreased steadily in both groups and there was no significant
difference between the two groups.
The severity of CL lesions was significantly different among the
opium addicted and non–addicted patients (P,0.001, Table 4).
The mean number of lesions (108 vs 104), the mean duration of
the lesions (5 vs 3.6 months) and the mean diameter of the lesions
(3.1 vs 2.1 cm) which were significantly higher in the opium
addicted individuals compared to non–addicted CL patients.
Similarly, the anatomical distribution of the lesions were
significantly different (P,0.05) among the two groups (Fig. 2); in
the opium addicted group the lesions were on the hands (68.4%),
legs (18.4%), face (10.6%) and other locations (2.6%). In contrast,
in non-addicted patients the lesion distribution was hands (57.4%),
face (28.6%), legs (13.1%) and other sites (1.2%). There was no
statistical significant difference (P=0.7) in survival rates of opium
addicted and non-addicted groups (Fig. 3). The results of nested-
PCR showed 750bp fragments which corresponds with the L.
tropica species (Fig. 4).
Discussion
Leishmaniasis remains a significant public health challenge in
the Eastern Mediterranean Region and is endemic in 18 of the 23
countries of EMRO region including Iran [23]. Cutaneous
leishmaniasis due to L. tropica has been reported in Bam since
Figure 2. Location of the cutaneous leishmaniasis lesions in opium addicted and opium non – addicted cohorts.
doi:10.1371/journal.pone.0089043.g002
Figure 3. Kaplan-Meier survival estimates of cutaneous leishmaniasis in opium and opium non-addicted.
doi:10.1371/journal.pone.0089043.g003
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ancient times [9]. After the major earthquake of 2003, opium
consumption has sharply increased in Bam, primarily as a result of
psychological distress and post-traumatic stress disorder. The latter
is a severe anxiety, developed after exposure to a major event such
as an earthquake [24]. It was previously shown that disasters have
significant psychological and psychiatric consequences [25].
Currently, the willingness toward substance misuse is a
worldwide growing concern. The United Nations Office for Drug
Control considers drug addiction as one of the quadruplet crises in
the world and categorized Iran among the high-risk countries [3].
The main reason for increasing frequency of opium misuse
appears to be in large part due to increased demands for treatment
of chronic or acute pain [16]. The reasons for a seven-year follow-
up strategy was due to a high proportion of the population having
a CL scar. A mean scar rate of 14% was observed for the district,
while it was 40% in hyperendemic areas. Moreover, the scarcity of
the volunteer opium addicted participants was another limiting
factor.
The incidence rate of CL was similar in the two groups which
indicate that they share similar risk factors for CL. In fact, there
was no significant difference in CL incidence between the opium
addicted and non-addicted groups during follow up. The selected
populations were mainly indigenous and fairly stable, with similar
exposure rate to sand fly bites. The reason that the incidence rate
of CL increased significantly in 2006 is due to a variety of
environmental changes occurring after the earthquake which
affect the risk factors. Modification of the physical environment
following a major earthquake had a profound effect on the
abundance of vectors, level of transmission and creation of fly
breeding sites [11,13].
Severity of CL lesions in terms of the number, duration and size
of the lesion was significantly higher in opium addicted patients as
compared to non-addicted patients. The reason for the difference
in severity of the lesion is not known. However, there is evidence
indicating that alkaloid opoids such as morphine and heroin
induce a significant immunosuppressive effect [26,27] and
morphine depresses phagocytic cell function [28], natural killer
cell activity [29], delayed- type hypersensitivity [30], antibody
formation [31] and reactive oxygen and nitrogen intermediates by
phagocytes [28,32]. Morphine is known to be an immunomod-
ulator in a mouse model of Leishmania donovani [33] and Toxoplasma
gondii infections [34]. In addition loss of appetite, as a main risk
factor, obviously restricts the availability of nutrients to drug
abusers [35]. Such a deprivation of food intake, in turn, could have
a deleterious effect on the addicts immune system. Other
precipitating factors include low motivation for treatment,
perceived stigma or fear of narcotic withdrawal if hospitalized all
of which may also play a role in the severity of the lesions.
Location of the lesions was different before and after the
earthquake. Lesions were more frequent on the face before
earthquake and more frequent on the hands after the earthquake
in the both groups. The lesions were more frequent on hands and
legs in opium addicts compared to non-addicted individuals and
the majority of the lesions were on hands and face in non-addicted
patients. The reason is not known but might be related to the
behaviour of the drug abusers, adult sand flies are mainly
Figure 4. Agarose gel electrophoresis prepared for amplifica-
tion of variable minicircle fragments of Leishmania kDNA by the
nested PCR. Lane 1, DNA size marker, 100 bp; lane 2, negative
control (distilled water); lane 3, L.major (positive control,
560 bp); lane 4, L.tropica (positive control,750 bp); lanes 5–7,
L.tropica isolates obtained from the cutaneous leishmaniasis
cases among opium addicted and opium non-addicted co-
horts.
doi:10.1371/journal.pone.0089043.g004
Table 4. The Severity of cutaneous leishmaniasis cases in opium addicted and non –addicted cohorts in terms of the number,
duration and size of the lesions.
Characteristics
Opium addicted
No (% )
Opium non –addicted
No (% )
No of lesions * 1 22(57.9) 63(73.3)
2 8(21.0) 13(15.1)
$3 8(21.1) 10(11.6)
Duration of lesions *(month) ,3 13(34.2) 45(52.3)
3–6 11(28.9) 24(27.9)
7–9 9(23.7) 13(15.1)
.9 5(13.2) 4(4.7)
Size of lesions *(cm) ,1 10(26.3) 33(38.4)
1–3 12(31.6) 39(45.3)
4–5 9(23.7) 11(12.8)
.5 7(18.4) 3(3.5)
*There was a significant difference between opium addicted and opium non –addicted cohorts (P,0.001).
doi:10.1371/journal.pone.0089043.t004
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nocturnal and the peak activity is commonly after sunset which is
the time that most addicts smoke opium [36].
In conclusion, the current findings strongly suggest that in
endemic foci, major disasters such as earthquakes might create a
variety of risk factors, which in turn provide a suitable condition
for transmission of CL and intensification of opium consumption.
The chance of contracting ACL due to L. tropica was similar
among opium addicted and non-addicted individuals however, the
lesions were significantly more severe in opium addicts than in
non-addicted patients.
Acknowledgments
The authors would like to thank the households and Bam health personnel
for their efforts and help in conducting this study.
Author Contributions
Conceived and designed the experiments: MRA IS ARF. Performed the
experiments: MHP BA MS AK. Analyzed the data: AK HS. Contributed
reagents/materials/analysis tools: MHP AK. Wrote the paper: IS.
References
1. United Nations Office on Drugs and Crime website. Available: www.unodc.org/
documents/data-and-analysis/WDR2011/WDR2011-web.pdf. Accessed 2011
October 4.
2. United Nations Office on Drugs and Crime website. Available: http://www.
unodc.org/documents/data-and-analysis/Studies/Afghan-Drug-Survey-2009-
Executive-Summary-web.pdf. Accessed 2011 October 12.
3. United Nations (2003) Global illicit drug trends: Pretoria: UNODC New York.
101–136.
4. United Nations Office on Drugs and Crime website. Available: http://www.
unodc.org/documents/data-and-analysis/WDR2012/WDR_2012_web_ small.
pdf. Accessed 2012 August 22.
5. Farnia M, Ebrahimi B, Shams A & Zamani S (2010) Scaling up methadone
maintenance treatment for opioid-dependent prisoners in Iran. Inter J Drug
Policy21: 422–4.
6. World Health Organization (WHO) (2010) Control of the leishmaniases. Report
of a Meeting of the WHO Expert Committee on the Control of Leishmaniases,
WHO Technical Report Series 949, Geneva. 1–187.
7. Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp
Immunol Microbiol Infect Dis 27: 305–318.
8. Ashford RW (2000) The leishmaniasis as emerging and re-emerging zoonoses.
Inter J Parasitol 30: 1269–1281.
9. Nadim A, Aflatoonian MR (1995) Anthroponotic cutaneous leishmaniasis in
Bam, southeast Iran. Iran J Public Health 24: 15–24.
10. Shirzadi MR, Gouya MM (2010) National Guidelines for cutaneous leishman-
iasis surveillance in Iran, M.o.H.a.M.E. Zoonoses Control Department, Tehran,
I.R. Iran, 1–78.
11. Desjeux P (2001) The increase in risk factors for the leishmaniasis worldwide.
Tran Roy Soc Trop Med Hyg 95: 239–43.
12. Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin
Microbiol Rev 19: 11–26.
13. Sharifi I, Nakhaei N, Aflatoonian MR, Hakimi Parizi M, Fekri AR, et al (2011)
Cutaneous leishmaniasis in Bam: A comparative evaluation of pre- and post-
earthquake years (1999–2008). Iranian J Publ Health 40: 49–56.
14. Seyedin SH, Aflatoonian MR, Ryan J (2009) Adverse impact of international
NGOs during and after the Bam earthquake: health system’s consumers’ points
of view. Am J Disaster Med 4(3): 173–9.
15. Montazeri A, Baradaran H, Omidvari S, Azin SA, Ebadi M, et al (2005)
Psychological distress among Bam earthquake survivors in Iran: a population-
based study. BMC Public Health 11: 4.
16. Mc Quay H (1999) Opioids in pain management. Lancet 353: 2229–32.
17. Ahmadi J, Pridmore S, Alimi A, Cheraghi A, Arad A, et al (2007) Epidemiology
of opium use in the general population. Am J Drug Alcohol Abuse 33: 483–91.
18. Aflatoonian MR, Meymandi MS, Divsalar K, Mahmoudi M, Heravi G (2011)
Possible association between human blood types and opioid addiction.
Am J Addict 20: 581–4.
19. Ziaaddini H, Ziaaddini MR (2005) The household survey of drug abuse in
Kerman, Iran. J Applied Sci 5: 380–382.
20. Gilrame E (2000) Substance abuse in young people. J Child Psychol Psyc 41:
55280.
21. Sokal JE (1975) Editorial: Measurement of delayed skin-test responses.
N Eng J Med 293: 501–502.
22. Noyes HA, Reyburn H, Bailey JW, Smith D (1998) A nested-PCR-based
schizodeme method for identifying Leishmania kinetoplast minicircle classes
directly from clinical samples and its application to the study of the epidemiology
of Leishmania tropica in Pakistan. J Clin Microbiol 36: 2877–81.
23. Postigo JA (2010) Leishmaniasis in the World Health Organization Eastern
Mediterranean Region. Int J Antimicrob Agents36: 62–5.
24. Mousavi SS, Mahmoudi-gharaei J, Bina M, Gholampoor E, Eisar S (2006) Post
traumatic stress disorder and general symptoms of anxiety in adolescent
survivors of Bam earthquake. Iran J Psychiatry 1: 76–80.
25. Galea S, Ahern J, Resnick H, Kilpatrick D, Bucuvalas M, et al. (2002)
Psychological squeal of the september 11 terrorist attacks in New York city.
N Engl J Med 346: 982–987.
26. Sacerdote P, Manfredi B, Mantegazza P, Panerai AE (1997) Antinociceptive and
immunosuppressive effects of opiate drugs: a structure-related activity study.
Br J Pharmacol 121: 834–840.
27. Wei G, Moss J, Yuan CS (2003) Opioid-induced immunosuppression: is it
centrally mediated or peripherally mediated? Biochem Pharmacol 65: 1761–6.
28. Peterson PK, Sharp B, Gekker G, Brummitt C, Keane WF (1987) Opioid
mediated suppression of cultured peripheral blood mononuclear cell respiratory
burst activity. J Immunol 138: 3907e12.
29. Yeager MP, Colacchio TA, Yu CT, Hildebrandt L, Howell AL, et al. (1995)
Morphine inhibits spontaneous and cytokine-enhanced natural killer cell
cytotoxicity in volunteers. Anesthesiol 83: 500e8.
30. Molitor TW, Morilla A, Risdahl JM, Murtaugh MP, Chao CC, et al. (1992)
Chronic morphine administration impairs cell-mediated immune responses in
swine. J Pharmacol Exp Ther 260: 581e6.
31. Bussiere JL, Adler MW, Rogers TJ, Eisenstein TK (1992) Differential effects of
morphine and naltrexone on the antibody response in various mouse strains.
Immunopharmacol Immunotoxicol 14: 657e73.
32. Lysle DT, How T (2000) Heroin modulates the expression of inducible nitric
oxide syntheses. Immunopharmacology 46: 181e92.
33. Singh PP, Singal P (2007) Morphine-induced neuroimmunomodulation in
murine visceral leishmaniasis: the role (s) of cytokines and nitric oxide.
J Neuroimmune Pharmacol 2: 338–351.
34. Chao CC, Sharp BM, Pomeroy C, Filice GA, Peterson PK (1990) Lethality of
morphine in mice infected with Toxoplasma gondii. J PharmacolExpTher252:
605–609.
35. Voukassovitch C (1986) [Drug addiction, anorexia: what is the connection?].
Ann Med Psychol 144: 695–709.
36. Guernaoui S, Boussaa S, Pesson B, Boumezzough A (2006) Nocturnal activity of
phlebotomine sandflies (Diptera: Psychodidae) in a cutaneous leishmaniasis focus
in Chichaoua, Morocco. Parasitol Res98(3): 184–8.
Cutaneous Leishmaniasis and Opium Addicts
PLOS ONE | www.plosone.org 6 February 2014 | Volume 9 | Issue 2 | e89043
